Association of Connexin 32 with Prostate Volume and PSA Level in Prostatic Adenocarcinoma and Adenomyomatous Hyperplasia

Creative Commons License

ERDEM H., ÇIRAKOĞLU A., BENLİ E., ÇANKAYA S.

JOURNAL OF UROLOGICAL SURGERY, cilt.7, sa.2, ss.103-108, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/jus.galenos2019.3042
  • Dergi Adı: JOURNAL OF UROLOGICAL SURGERY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.103-108
  • Anahtar Kelimeler: Prostatic adenocarcinomas, Adenomyomatous hyperplasia, Prostate-specific antigen, Prostate volume, ANTIGEN, EXPRESSION, CANCER, PROGRESSION, CARCINOMA, PATHOLOGY, DENSITY, GENES, MOUSE, SERUM
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Objective: Prostate cancer (PC) is the second most common cancer in men in the world. PC is associated with many parameters. Connexins may also be prognostic parameters in this study, we aimed to evaluate Cx32 expression in prostatic adenocarcinomas (PCa) and adenomyomatous hyperplasia (AH). In addition, age, prostate-specific antigen (PSA) level, prostate volume (PV), Gleason score (GS) (and grade group) were also evaluated.